Canadian glyphosate-cancer lawsuits against Bayer may proceed regardless of US settlement

roundup

…. [T]he agreements, between Bayer and numerous law firms in America, donโ€™t apply to potential class action lawsuits in Canada, said Tony Merchant, founder of Merchant Law Group.

โ€œWe donโ€™t really know, right now, where this will lead,โ€ Merchant said …. โ€œWe have to go forward with the certification actions that we have underway. And try to press Bayer to deal fairly with (claims) in Canada.โ€

Bayer has been facing thousands of legal cases in the United States, and elsewhere, where claimants said exposure to glyphosate (the active ingredient in Roundup) contributed to their development of cancer.

Bayerโ€™s legal troubles began after the company acquired Monsanto, the maker of Roundup herbicide, in 2016. The takeover was finalized in 2018. Payments of $10.1 โ€“ $10.9 billion should resolve the majority of the lawsuits in America, Bayer said in a statement.

In May of 2019, Merchant said his firm was trying to certify a class action suit against Bayer. The lead plaintiff in the case is Garry Gadd, a farmer from Moose Jaw, Sask. Gadd claims that exposure to glyphosate contributed to his cancer. He was diagnosed with non-Hodgkinโ€™s Lymphoma in 2014.

In Canada, a judge must certify a case before it can proceed as a class action. Initially, less than 12 Canadians had joined the Merchant Law Group case.

As of late June, the number was much higher. โ€œSlightly over 500,โ€ Merchant said.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: โ€˜Safer for children?โ€™ Stonyfield yogurt under fire for deceptive organic marketing
the magic of mRNA
Viewpoint: Anti-vax fake โ€˜turbo cancerโ€™ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates โ€˜skyrocketingโ€™ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
artificial intelligence brain think illustration md
Viewpoint โ€” Digital gods and human extinction: Will we be the first species ever to design our own descendants?
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformationย 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.